Home › NCT06608758
End Diagnostic Overshadowing
End Diagnostic Overshadowing: Understanding and Reducing Diagnostic Error in Patients With Disabilities
Who can join
Ages 3 to 89 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: • Patients aged 3-89 who received billed charges Exclusion Criteria: * Patients under age 3 or over age 89. * Patients with secondary diagnosis of dementia as the population is already known to be at increased risk of diagnostic error
About the study
The goal of this study is to address the critical issue of diagnostic overshadowing by applying the Collective Impact Model40 to co-produce our End Diagnostic Overshadowing program with academic, health systems, health professional, PWDs, family members, and community stakeholders. Through this work, we will identify and address mechanisms that contribute to diagnostic overshadowing and diagnostic errors among people with disabilities. The main questions to answer are whether knowledge about diagnostic errors and confidence will improve with health care providers and professionals involved in diagnostic provesses, whether developed algorithms to identify patients at risk of diagnpstic error will be used, whether there will be change in time to diagnostic evaluation for PWD from the specified 5 population groups and with the specified diagnoses prone to error, and whether changes in usage of CPT Evaluation and Management codes will occur.
What is being tested
- Electonic health record prompts with education (behavioral)
- Standard of care (other)
Sponsor: Rush University Medical Center · Participants: 120,000 · Started: Nov 22, 2024
Contact the study team
- Director Research Affairs · Phone: 312-942-3554
- Tricia J Johnson, PhD · Phone: 312-942-7107
Official record on ClinicalTrials.gov — NCT06608758
Locations in the U.S.
| Illinois | Rush University Medical Center, Chicago |
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.